PLUS1
0.3138
-0.0464 (-12.88%)
-0.0464 (-12.88%)
Upgrade to Real-Time
Afterhours
| Volume | 252,600 |
|
|||||
| News | - | ||||||
| Day High | 0.37 | Low High |
|||||
| Day Low | 0.3001 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Gelesis Holdings Inc | GLS | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0464 | -12.88% | 0.3138 | 16:16:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3699 | 0.3001 | 0.37 | 0.3015 | 0.3602 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 626 | 252,600 | $ 0.32883 | $ 83,062 | - | 0.221 - 6.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:13:04 | formt | 100 | $ 0.3138 | USD |
Period:
Draw Mode:
Gelesis Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 22.92M | 73.03M | 20.07M | $ 11.19M | $ - | -2.60 | -0.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 100.00k | 6.50% |
Gelesis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.368 | 0.41 | 0.3001 | 0.377282 | 97,307 | -0.0542 | -14.73% |
| 1 Month | 0.2845 | 0.54 | 0.2635 | 0.4125648 | 133,511 | 0.0293 | 10.3% |
| 3 Months | 0.28 | 0.5499 | 0.221 | 0.3554151 | 153,144 | 0.0338 | 12.07% |
| 6 Months | 1.35 | 1.77 | 0.221 | 0.681489 | 138,627 | -1.04 | -76.76% |
| 1 Year | 4.94 | 6.25 | 0.221 | 2.47 | 186,013 | -4.63 | -93.65% |
| 3 Years | 7.36 | 8.24 | 0.221 | 2.61 | 187,086 | -7.05 | -95.74% |
| 5 Years | 7.36 | 8.24 | 0.221 | 2.61 | 187,086 | -7.05 | -95.74% |
Gelesis Description
| Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation. |